AUS
NZ
UK
CA
USA
IND
Health
Viking Therapeutics (NASDAQ: VKTX) to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 06, 2025 10:20 PM PST| By Team Kalkine MediaHighlights,Viking Therapeutics CEO Brian Lian to present on January 13, 2025, at the J.P. Morgan Healthcare Conference,The presentation will be available via live webcast for investors and stakeholders,Viking Therapeutics continues to focus on develo...
Could Market Trends Be Signaling Trouble for Xenon Pharmaceuticals?
January 06, 2025 02:42 AM PST| By Team Kalkine MediaHighlights,Xenon Pharmaceuticals operates within the biotechnology sector, focusing on treatments for neurological disorders.,Shares of Xenon Pharmaceuticals began trading at a price above their short-term average on Monday.,The company exhibits a st...
N4 Pharma: Navigating Market Challenges with Innovative Drug Delivery Technologies
January 06, 2025 02:41 AM PST| By Team Kalkine MediaHeadlines,N4 Pharma experiences significant drop in stock price,The company specializes in novel drug delivery systems for oncology and gene therapy,N4 Pharma’s unique delivery technologies could drive future growth,N4 Pharma Faces Decline Amid Marke...
AEON Biopharma (NYSE: AEON) Announces Proposed Public Offering to Raise Capital for Corporate Needs
January 05, 2025 07:22 PM PST| By Team Kalkine MediaHighlights,Plans to raise capital through units comprising common stock and warrants to purchase stock.,Aegis Capital Corp. appointed as book-running manager for the offering.,Net proceeds intended for general corporate and working capital purposes.,...
Bristol-Myers Squibb (NYSE:BMY) Exceeds Expectations, Raises Dividend
January 03, 2025 08:40 AM PST| By Team Kalkine MediaHighlights,Bristol-Myers Squibb sees a massive surge in call options.,The company exceeds earnings expectations with strong revenue growth.,Dividend,hike reflects Bristol-Myers Squibb’s ongoing commitment to shareholders.,Bristol-Myers Squibb Company...
Johnson & Johnson (NYSE:JNJ) Sees Modest Increase After Dividend Declaration
January 03, 2025 08:05 AM PST| By Team Kalkine MediaHighlights,Johnson & Johnson stock saw a 0.2% rise following a dividend announcement.,Shares traded as high as $145.77, with 1.2 million shares exchanged.,The company reported strong earnings with revenue growth in its recent quarter.,Johnson & Johns...
_01_03_2025_18_49_52_768962.jpg)
Analyzing Capital Allocation at U.S. Physical Therapy (NYSE:USPH)
January 03, 2025 07:48 AM PST| By Team Kalkine MediaHighlights,S. Physical Therapy has seen a decline in returns on capital.,Capital allocation trends have not significantly boosted sales.,The stock has fallen by 17% in the past five years, reflecting market doubts.,U.S. Physical Therapy Inc. has been...
Why Is Heron Therapeutics Struggling to Regain Its Momentum?
January 03, 2025 02:55 AM PST| By Team Kalkine MediaHighlights,Heron Therapeutics focuses on pain and nausea therapeutic solutions.,Recent stock price movements reflect diverse market activity trends.,The company operates in the innovative biopharmaceutical sector.,Heron Therapeutics,(NASDAQ:HRTX),ope...
ResMed (NYSE:RMD) Navigating the Changing Market Dynamic
January 02, 2025 10:17 AM PST| By Team Kalkine MediaHighlights,ResMed's stock price dips below its 200-day moving average.,The company posted strong quarterly earnings, exceeding expectations.,ResMed continues to grow with a strong market presence in medical devices.,ResMed Inc. recently saw its stock...
The Role of Acquisitions in Thermo Fisher’s (NYSE:TMO) Stability
January 02, 2025 08:55 AM PST| By Team Kalkine MediaHighlights,Thermo Fisher offers innovative life science and diagnostic solutions.,The company’s recent acquisitions enhance its market position.,Current market volatility does not seem to significantly affect TMO’s growth prospects.,In the ever-evolv...
Could Roivant's Ties to Government Shake Up the Biotech Industry?
January 02, 2025 02:50 AM PST| By Team Kalkine MediaHighlights,Biotechnology company focused on patents and medicine development.,Owns diverse subsidiaries in various biotechnology domains.,Known for regulatory expertise and operational efficiency.,The biotechnology sector is a vital contributor to he...
Why Is Geron Corp. Gaining Momentum Amid Year-End Trading?
January 02, 2025 02:44 AM PST| By Team Kalkine MediaHighlights,Geron Corporation's focus on treatments for myelodysplastic syndromes gains attention.,Recent European Medicines Agency recommendation boosts market sentiment for the company.,Continuous rally in share price marks an impressive year-end pe...
Is Thermo Fisher Struggling Amid Biopharma and Political Uncertainty?
January 02, 2025 02:32 AM PST| By Team Kalkine MediaHighlights,Thermo Fisher supports life sciences and laboratory research with diverse products.,Recent acquisitions enhance capabilities in proteomics and protein diagnostics.,Market challenges include uncertainties in biopharma and geopolitical risks...
Why Has Amphastar's Stock Taken a Drastic Turn This Year?
January 02, 2025 12:54 AM PST| By Team Kalkine MediaHighlights,Amphastar Pharmaceuticals operates in the pharmaceutical and healthcare sector.,Amphastar reflects stable liquidity ratios and moderate debt levels.,The stock's 1-year range shows dynamic market movements.,Amphastar Pharmaceuticals,(NASDAQ...
Why Did GE HealthCare Shares Decline Amid High Trading Volume?
January 02, 2025 12:25 AM PST| By Team Kalkine MediaHighlights,GE HealthCare Technologies operates within the healthcare equipment sector.,GEHC stock recently saw a slight decrease in trading value.,Financial metrics indicate stable market capitalization and ratios.,GE HealthCare Technologies,(NASDAQ:...
Kazia Therapeutics (NASDAQ: KZIA) Provides Update on FDA Meeting Regarding Paxalisib for Glioblastoma Treatment
January 02, 2025 12:22 AM PST| By Team Kalkine MediaHighlights,FDA aligns with Kazia on Phase 3 study design for paxalisib in glioblastoma.,3.8-month survival improvement in GBM-AGILE trial strengthens treatment potential.,Orphan Drug and Rare Pediatric Disease Designations bolster pediatric applicati...
Analyst Insights on Stryker's Strategic Position and Future
January 01, 2025 10:34 PM PST| By Team Kalkine MediaHeadlines,Stryker's Strategic Outlook: Insights and Updates,Analyst Revisions and Future Perspectives,Stryker's Position in the Healthcare Landscape,Stryker Corporation,(NYSE:SYK),recently received a revision in its analyst ratings. StockNews.com adj...
Avantor's Short Interest Drop Signals Shifting Market Sentiment
January 01, 2025 10:05 PM PST| By Team Kalkine MediaHeadlines,Avantor experiences a decrease in short interest.,Significant institutional investments in Avantor shares.,Analysts have varying views, but the stock receives favorable ratings.,Avantor, Inc.,(NYSE:AVTR),has recently seen a noteworthy drop...
Select Medical (NYSE:SEM) A Deep Dive into Financials
December 31, 2024 09:39 AM PST| By Team Kalkine MediaHighlights,Significant changes in holdings by institutional investors.,Spanning critical illness recovery, rehabilitation, and outpatient clinics.,Highlighting debt ratios, P/E ratios, and recent trading ranges.,Select Medical Holdings continues to r...
Eli Lilly and Company (NYSE:LLY) Continues to Lead in Healthcare Innovation
December 31, 2024 09:36 AM PST| By Team Kalkine MediaHighlights,Marjorie Taylor Greene (R-Georgia) buys shares in Eli Lilly.,Eli Lilly shows strong stock performance with solid revenue growth.,Eli Lilly announces $15 billion stock buyback and dividend increase.,Representative Marjorie Taylor Greene (R-...
